Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP

Study objectives This study tries to assess the endothelial function in vivo using flow-mediated dilatation (FMD) and several biomarkers of endothelium formation/restoration and damage in patients with obstructive sleep apnoea (OSA) syndrome at baseline and after three months with CPAP therapy. Desi...

Descripción completa

Detalles Bibliográficos
Autores: Muñoz Hernández, Rocío, Vallejo Vaz, Antonio Javier, Sánchez Armengol, María de los Ángeles, Moreno Luna, Rafael, Caballero Eraso, Candelaria, Macher, Hada, Villar, José, Stiefel García-Junco, Pablo Enrique
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/152617
Acceso en línea:https://hdl.handle.net/11441/152617
https://doi.org/10.1371/journal.pone.0122091
Access Level:acceso abierto
id ES_32045f977b511671c95b7ace7b797f31
oai_identifier_str oai:idus.us.es:11441/152617
network_acronym_str ES
network_name_str España
repository_id_str
spelling Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAPMuñoz Hernández, RocíoVallejo Vaz, Antonio JavierSánchez Armengol, María de los ÁngelesMoreno Luna, RafaelCaballero Eraso, CandelariaMacher, HadaVillar, JoséStiefel García-Junco, Pablo EnriqueStudy objectives This study tries to assess the endothelial function in vivo using flow-mediated dilatation (FMD) and several biomarkers of endothelium formation/restoration and damage in patients with obstructive sleep apnoea (OSA) syndrome at baseline and after three months with CPAP therapy. Design Observational study, before and after CPAP therapy. Setting and Patients We studied 30 patients with apnoea/hypopnoea index (AHI) >15/h that were compared with themselves after three months of CPAP therapy. FMD was assessed non-invasively in vivo using the Laser-Doppler flowmetry. Circulating cell-free DNA (cf-DNA) and microparticles (MPs) were measured as markers of endothelial damage and the vascular endothelial growth factor (VEGF) was determined as a marker of endothelial restoration process. Measurements and results After three month with CPAP, FMD significantly increased (1072.26 ± 483.21 vs. 1604.38 ± 915.69 PU, p< 0.005) cf-DNA and MPs significantly decreased (187.93 ± 115.81vs. 121.28 ± 78.98 pg/ml, p<0.01, and 69.60 ± 62.60 vs. 39.82 ± 22.14 U/μL, p<0.05, respectively) and VEGF levels increased (585.02 ± 246.06 vs. 641.11 ± 212.69 pg/ml, p<0.05). These changes were higher in patients with more severe disease. There was a relationship between markers of damage (r = -0.53, p<0.005) but not between markers of damage and restoration, thus suggesting that both types of markers should be measured together. Conclusions CPAP therapy improves FMD. This improvement may be related to an increase of endothelial restoration process and a decrease of endothelial damage.Public Library of ScienceFisiologíaMedicina2015info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://hdl.handle.net/11441/152617https://doi.org/10.1371/journal.pone.0122091reponame:idUS. Depósito de Investigación de la Universidad de Sevillainstname:Universidad de Sevilla (US)InglésPLoS ONE, 10 (3), e0122091.https://doi.org/10.1371/journal.pone.0122091info:eu-repo/semantics/openAccessoai:idus.us.es:11441/1526172026-06-17T12:51:07Z
dc.title.none.fl_str_mv Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
title Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
spellingShingle Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
Muñoz Hernández, Rocío
title_short Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
title_full Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
title_fullStr Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
title_full_unstemmed Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
title_sort Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
dc.creator.none.fl_str_mv Muñoz Hernández, Rocío
Vallejo Vaz, Antonio Javier
Sánchez Armengol, María de los Ángeles
Moreno Luna, Rafael
Caballero Eraso, Candelaria
Macher, Hada
Villar, José
Stiefel García-Junco, Pablo Enrique
author Muñoz Hernández, Rocío
author_facet Muñoz Hernández, Rocío
Vallejo Vaz, Antonio Javier
Sánchez Armengol, María de los Ángeles
Moreno Luna, Rafael
Caballero Eraso, Candelaria
Macher, Hada
Villar, José
Stiefel García-Junco, Pablo Enrique
author_role author
author2 Vallejo Vaz, Antonio Javier
Sánchez Armengol, María de los Ángeles
Moreno Luna, Rafael
Caballero Eraso, Candelaria
Macher, Hada
Villar, José
Stiefel García-Junco, Pablo Enrique
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Fisiología
Medicina
description Study objectives This study tries to assess the endothelial function in vivo using flow-mediated dilatation (FMD) and several biomarkers of endothelium formation/restoration and damage in patients with obstructive sleep apnoea (OSA) syndrome at baseline and after three months with CPAP therapy. Design Observational study, before and after CPAP therapy. Setting and Patients We studied 30 patients with apnoea/hypopnoea index (AHI) >15/h that were compared with themselves after three months of CPAP therapy. FMD was assessed non-invasively in vivo using the Laser-Doppler flowmetry. Circulating cell-free DNA (cf-DNA) and microparticles (MPs) were measured as markers of endothelial damage and the vascular endothelial growth factor (VEGF) was determined as a marker of endothelial restoration process. Measurements and results After three month with CPAP, FMD significantly increased (1072.26 ± 483.21 vs. 1604.38 ± 915.69 PU, p< 0.005) cf-DNA and MPs significantly decreased (187.93 ± 115.81vs. 121.28 ± 78.98 pg/ml, p<0.01, and 69.60 ± 62.60 vs. 39.82 ± 22.14 U/μL, p<0.05, respectively) and VEGF levels increased (585.02 ± 246.06 vs. 641.11 ± 212.69 pg/ml, p<0.05). These changes were higher in patients with more severe disease. There was a relationship between markers of damage (r = -0.53, p<0.005) but not between markers of damage and restoration, thus suggesting that both types of markers should be measured together. Conclusions CPAP therapy improves FMD. This improvement may be related to an increase of endothelial restoration process and a decrease of endothelial damage.
publishDate 2015
dc.date.none.fl_str_mv 2015
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/11441/152617
https://doi.org/10.1371/journal.pone.0122091
url https://hdl.handle.net/11441/152617
https://doi.org/10.1371/journal.pone.0122091
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv PLoS ONE, 10 (3), e0122091.
https://doi.org/10.1371/journal.pone.0122091
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Public Library of Science
publisher.none.fl_str_mv Public Library of Science
dc.source.none.fl_str_mv reponame:idUS. Depósito de Investigación de la Universidad de Sevilla
instname:Universidad de Sevilla (US)
instname_str Universidad de Sevilla (US)
reponame_str idUS. Depósito de Investigación de la Universidad de Sevilla
collection idUS. Depósito de Investigación de la Universidad de Sevilla
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869405648793370624
score 15.300719